These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4154991)

  • 21. Ergot alkaloids as dopamine agonists: comparison in two rodent models.
    Anlezark G; Pycock C; Meldrum B
    Eur J Pharmacol; 1976 Jun; 37(2):295-302. PubMed ID: 986304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipsychotic and antidyskinetic properties of ergot dopamine agonists.
    Tamminga CA
    Adv Biochem Psychopharmacol; 1980; 23():397-403. PubMed ID: 7395624
    [No Abstract]   [Full Text] [Related]  

  • 23. Ergot treatment of nonpuerperal galactorrhea.
    N Engl J Med; 1972 Oct; 287(14):723. PubMed ID: 5055426
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug interaction--propranolol and cafergot.
    Baumrucker JF
    N Engl J Med; 1973 Apr; 288(17):916-7. PubMed ID: 4693950
    [No Abstract]   [Full Text] [Related]  

  • 25. Prolactin inhibition and suppression of puerperal lactation by a Br-erocryptine (CB 154). A comparison with estrogen.
    Brun del Re R; Del Pozo E; De Grandi P; Friesen H; Hinselmann M; Wyss H
    Obstet Gynecol; 1973 Jun; 41(6):884-90. PubMed ID: 4708482
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurochemical bases of tremor and other disorders of movement.
    Sourkes TL; Poirier LJ
    Can Med Assoc J; 1966 Jan; 94(2):53-60. PubMed ID: 4380339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dyskinesias elicited by methamphetamine: susceptibility of former methadone-consuming monkeys.
    Eibergen RD; Carlson KR
    Science; 1975 Nov; 190(4214):588-90. PubMed ID: 810889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).
    Del Pozo E; Del Re RB; Varga L; Friesen H
    J Clin Endocrinol Metab; 1972 Nov; 35(5):768-71. PubMed ID: 4672297
    [No Abstract]   [Full Text] [Related]  

  • 29. [Inhibition of lactation with 2 Br-alpha-ergocryptine].
    Jaszmann L; Szabó E; Szontágh F
    Orv Hetil; 1974 Sep; 115(35):2053-4. PubMed ID: 4603634
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of migraine by reducing prolactin levels.
    Horrobin DF
    Lancet; 1973 Apr; 1(7806):777. PubMed ID: 4120760
    [No Abstract]   [Full Text] [Related]  

  • 31. Ergot alkaloids and central monoaminergic receptors.
    Goldstein M
    J Pharmacol; 1985; 16 Suppl 3():19-24. PubMed ID: 3005775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain.
    Burt DR; Creese I; Snyder SH
    Mol Pharmacol; 1976 Jul; 12(4):631-8. PubMed ID: 958211
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of DL dopa on harmaline induced tremor and on resting tremor in monkeys with tegmental lesions.
    Battista AF; Nakatani S; Goldstein M
    Confin Neurol; 1970; 32(2):332-40. PubMed ID: 4993817
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experience with a new peripheral vasodilator agent, in which are combined raubasine, and 2 ergot alkaloids in the treatment of peripheral diabetic angiopathy].
    Martínez-López JM; Calvo-Fernández R; Garrido-Toro A; Sánchez-Cañaveral F
    Angiologia; 1973; 25(4):195-8. PubMed ID: 4717702
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparative study of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in oclular normotensive and alpha-chymotrypsin-induced ocular hypertensive rabbits.
    Puras G; Santafé J; Segarra J; Garrido M; Melena J
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1559-67. PubMed ID: 17505840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromocriptine and dopamine-receptor stimulation.
    Dray A; Oakley NR
    J Pharm Pharmacol; 1976 Jul; 28(7):586-8. PubMed ID: 8616
    [No Abstract]   [Full Text] [Related]  

  • 37. Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.
    Besser GM; Parke L; Edwards CR; Forsyth IA; McNeilly AS
    Br Med J; 1972 Sep; 3(5828):669-72. PubMed ID: 4675488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on the neuronal circuits implicated in postural tremor and hypokinesia].
    Poirier LJ; Bouvier G; Bedard P; Boucher R; Larochelle L; Olivier A; Singh P
    Rev Neurol (Paris); 1969 Jan; 120(1):15-40. PubMed ID: 4985103
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacological basis for the therapeutic use of ergot alkaloids].
    Tran MA; Montastruc JL; Montastruc P
    Presse Med; 1983 Feb; 12(8):517-20. PubMed ID: 6131414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of centrally acting drugs on tremor in monkeys with mesencephalic lesions.
    Goldstein M; Battista AF; Nakatani S; Anagnoste B
    Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1113-6. PubMed ID: 4982245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.